Cheng-Jiang Wei
Overview
Explore the profile of Cheng-Jiang Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei C, Tang Y, Sun Y, Yang T, Yan C, Liu H, et al.
NPJ Digit Med
. 2025 Jan;
8(1):56.
PMID: 39863790
Deep-learning models have shown promise in differentiating between benign and malignant lesions. Previous studies have primarily focused on specific anatomical regions, overlooking tumors occurring throughout the body with highly heterogeneous...
2.
Ge L, Wang Z, Wei C, Huang J, Liu J, Gu Y, et al.
Cancer Immunol Immunother
. 2023 Nov;
72(12):4415-4429.
PMID: 37938367
Dermatofibrosarcoma protuberans (DFSP) stands as a rare and locally aggressive soft tissue tumor, characterized by intricated molecular alterations. The imperative to unravel the complexities of intratumor heterogeneity underscores effective clinical...
3.
Guo Z, Wang Z, Wang D, Ge L, Li Y, Gu Y, et al.
Eur J Med Res
. 2023 Jun;
28(1):185.
PMID: 37291616
Nowadays, laser is the mainstay treatment for cafe-au-lait macules (CALMs), but no systematic review has been published to demonstrate the overall efficacy and it's still controversial which type of laser...
4.
Ruan Q, Wang Z, Wei C, Wang W, Yang Q, Wu J, et al.
Signal Transduct Target Ther
. 2023 Jun;
8(1):233.
PMID: 37268605
No abstract available.
5.
6.
Wei C, Peng L, Chuang M, Wang Z, Wang B
Front Oncol
. 2022 Dec;
12:1007651.
PMID: 36505768
Tuberous sclerosis complex (TSC) is an inherited disorder that typically presents with seizures, developmental delay, cutaneous lesions, and facial angiomas. Clinical diagnosis of TSC based on symptoms is sometimes challenging...
7.
Wang Z, Li H, Wei C, Wang W, Li Q
Lancet Neurol
. 2022 Aug;
21(9):773-774.
PMID: 35963255
No abstract available.
8.
Liu J, Huang J, Wang M, Ni Z, Jiang W, Chung M, et al.
Front Oncol
. 2022 Jun;
12:898971.
PMID: 35677169
Neurofibromatosis type 1 (NF1) is a dominant hereditary disease characterized by the mutation of the gene, affecting 1/3000 individuals worldwide. Most NF1 patients are predisposed to benign peripheral nerve sheath...
9.
Wang W, Wei C, Cui X, Li Y, Gu Y, Gu B, et al.
Front Neurol
. 2021 Sep;
12:704639.
PMID: 34566848
Neurofibromatosis type 1 (NF1) is a tumor predisposition genetic disorder that directly affects more than 1 in 3,000 individuals worldwide. It results from mutations of the NF1 gene and shows...
10.
Wang W, Cui X, Gu Y, Wei C, Li Y, Ren J, et al.
J Invest Dermatol
. 2021 Sep;
142(3 Pt A):613-623.e7.
PMID: 34534577
MAPK/extracellular signal-regulated kinase kinase (MEK) 1/2 inhibitors (MEKis) have recently achieved surprising success in treating unresectable plexiform neurofibromas (PNFs). However, few studies have investigated the mechanisms of MEKi resistance in...